Search Within

Giulio Pesci

Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. Department of Medicine (8)
  2. GDMT, Medicine (8)
  3. Gynecologic Medicine Service (8)
  4. Gynecology Disease Management Team (8)
  5. Solid Tumor Oncology Division (8)
  6. Department of Pathology and Laboratory Medicine (5)

More Groups

People
  1. Dmitriy Zamarin (7)
  2. Aaron Praiss (4)
  3. Britta Weigelt (4)
  4. Hunter Green (4)
  5. Bharat Burman (3)
  6. Dennis Chi (3)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (3)
  4. 2022 (2)
  5. 2020 (1)
Publications
  1. Gynecologic Oncology (5)
  2. Cancers (1)
  3. Journal of Clinical Oncology (1)
  4. Nature Communications (1)
Publishers
  1. Elsevier Inc. (5)
  2. American Society of Clinical Oncology (1)
  3. MDPI (1)
  4. Nature Publishing Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: A randomized phase I trial
    Journal Article

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H. A.; Pesci, G.; Kim, H.; Chino, J. P.; Banbury, B.; Sherry, N.; Sharon, E.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Intraperitoneal therapy with engineered Newcastle disease virus encoding interleukin-12 in combination with PD-1 blockade for ovarian cancer
    Meeting Abstract

    Kahn, R.; Ozsoy, M. A.; Green, H.; Gill, K.; Praiss, A.; Pesci, G.; Burman, B.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Zhu, Y.; Derakhshan, F.; Hoang, T.; Pesci, G.; Green, H.; Hanlon, E.; Gardner, G.; Roche, K. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Surgical stress promotes IL-6-driven tumor progression in ovarian cancer
    Meeting Abstract

    Praiss, A.; Longhini, A. L. F.; Pesci, G.; Green, H.; Ozsoy, M.; Kahn, R.; Brodeur, M.; Bhaloo, S.; Merghoub, T.; Wolchok, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Safety and immunogenicity of anti PD-L1 (atezolizumab) given as an immune primer or concurrently with extended field chemoradiotherapy for node positive locally advanced cervical cancer: An NRG oncology trial
    Meeting Abstract

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; Pesci, G.; Park, K.; Banbury, B.; Sherry, N.; Ghamande, S.; Holman, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Study to evaluate intraperitoneal (IP) ONCOS-102 with systemic durvalumab in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Phase 2 results
    Meeting Abstract

    Zamarin, D.; Odunsi, K.; Zsiros, E.; Slomovitz, B. M.; Pimentel, A.; Duska, L. R.; Reilley, M.; Nemunaitis, J. J.; Hamouda, D. M.; Patel, H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Newcastle disease virus at the forefront of cancer immunotherapy
    Review

    Burman, B.; Pesci, G.; Zamarin, D.
    Cancers (2020)

    Fulltext@MSK | Save